TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/3/22 19:12 | 4/10/22 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Scott John K Jr. | OH | DT | P.d | 0 | 0.00 | 0 | 3 | 0 | 8,107 | D | |||||||||||||||
9/2/20 21:47 | 8/30/20 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Scott John K Jr. | CO | T | P | 25 | 5.00 | 0 | 5 | 0 | 8,057 | D | |||||||||||||||
2/19/20 15:58 | 2/13/20 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Scott John K Jr. | CO | T | P | 2,018 | 0.8500 | 0 | 2,374 | 42 | 8,052 | D | |||||||||||||||
12/11/19 11:11 | 12/6/19 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Scott John K Jr. | CO | T | P | 500 | 0.9000 | 0 | 556 | 11 | 5,679 | D | |||||||||||||||
6/21/19 20:50 | 6/18/19 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Scott John K Jr. | CO | T | P | 3,000 | 0.7500 | 0 | 4,000 | 356 | 5,123 | D | |||||||||||||||
3/25/19 17:36 | 3/22/19 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Scott John K Jr. | CO | T | P | 50 | 0.1400 | 0 | 357 | 2 | 22,464 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |